MACROGENICS, INC. Deferred Revenue (Non-Current)
MACROGENICS, INC. (MGNX) had Deferred Revenue (Non-Current) of $55.50 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2026-03-09
- 2025-12-31: Deferred Revenue, Noncurrent $55.50M.
- 2024-12-31: Deferred Revenue, Noncurrent $55.50M.
- 2023-12-31: Deferred Revenue, Noncurrent $59.24M.
- 2022-12-31: Deferred Revenue, Noncurrent $59.48M.
| Period end | Deferred Revenue, Noncurrent | Deferred Revenue, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $55.50M 10-K · filed 2026-03-09 | |
| 2024-12-31 | $55.50M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $59.24M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $59.48M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | |
| 2020-12-31 | $6.93M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $9.15M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $19.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $14.13M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $15.95M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $17.76M 10-Q · filed 2018-05-07 | |
| 2018-01-01 | $19.58M 10-K · filed 2019-02-26 | |
| 2017-12-31 | $13.64M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $8.44M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $9.24M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $8.98M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $10.04M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $9.79M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $10.74M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $11.69M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $12.63M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $11.89M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $12.72M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $14.39M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $16.47M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $19.05M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $23.91M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $17.16M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $7.14M 10-K · filed 2015-03-03 | $7.14M 10-K · filed 2014-03-20 |
| 2013-09-30 | $8.81M 10-Q · filed 2013-11-12 | |
| 2012-12-31 | $19.96M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |